Min Yuan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Interests
Min Yuan has a total of 76 co-authors. Here are the top co-authors by number of shared publications:
- John M. Asara
Division of Signal Transduction, Beth Israel Deaconess Medical Center, Boston, USA
46 shared publications - Benjamin D. Stein
Sandra and Edward Meyer Cancer Center, Department of Medicine, Weill Cornell Medicine, New York, New York
44 shared publications - Bryan Ngo
Sandra and Edward Meyer Cancer Center, Department of Medicine, Weill Cornell Medicine, New York, New York
44 shared publications - Chen Zhang
Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York
44 shared publications - David Wu
Sandra and Edward Meyer Cancer Center, Department of Medicine, Weill Cornell Medicine, New York, New York
44 shared publications - Eric Edison Gardner
Meyer Cancer Center, Weill Cornell Medicine
44 shared publications
Latest Publications
- Open Access
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Figure S2 from LKB1-Dependent Regulation of TPI1 Creates a Divergent Metabolic Liability between Human and Mouse Lung Adenocarcinoma
Figure S2. Phosphorylation of human TPI1 is LKB1-dependent.
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from LKB1-Dependent Regulation of TPI1 Creates a Divergent Metabolic Liability between Human and Mouse Lung Adenocarcinoma
Figure S2. Phosphorylation of human TPI1 is LKB1-dependent.
- Open Access
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Figure S1 from LKB1-Dependent Regulation of TPI1 Creates a Divergent Metabolic Liability between Human and Mouse Lung Adenocarcinoma
Figure S1. Differential co-occurrence and effects of KRAS, TP53 and LKB1 mutations on human and mouse LUADs.
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from LKB1-Dependent Regulation of TPI1 Creates a Divergent Metabolic Liability between Human and Mouse Lung Adenocarcinoma
Figure S1. Differential co-occurrence and effects of KRAS, TP53 and LKB1 mutations on human and mouse LUADs.
- Open Access
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Figure S5 from LKB1-Dependent Regulation of TPI1 Creates a Divergent Metabolic Liability between Human and Mouse Lung Adenocarcinoma
Figure S5. LKB1 regulates the multimeric state of hTPI1 but not mTpi1 and substitution of Cys in hTPI1 causes formation of a covalent TPI1 dimer.
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S5 from LKB1-Dependent Regulation of TPI1 Creates a Divergent Metabolic Liability between Human and Mouse Lung Adenocarcinoma
Figure S5. LKB1 regulates the multimeric state of hTPI1 but not mTpi1 and substitution of Cys in hTPI1 causes formation of a covalent TPI1 dimer.
- Open Access
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Figure S3 from LKB1-Dependent Regulation of TPI1 Creates a Divergent Metabolic Liability between Human and Mouse Lung Adenocarcinoma
Figure S3. TPI1 phosphorylation regulates triose phosphate levels and metabolic flux.
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from LKB1-Dependent Regulation of TPI1 Creates a Divergent Metabolic Liability between Human and Mouse Lung Adenocarcinoma
Figure S3. TPI1 phosphorylation regulates triose phosphate levels and metabolic flux.
- Open Access
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Figure S6 from LKB1-Dependent Regulation of TPI1 Creates a Divergent Metabolic Liability between Human and Mouse Lung Adenocarcinoma
Figure S6. TPI1 allelic variants effects central carbon metabolic flux.
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S6 from LKB1-Dependent Regulation of TPI1 Creates a Divergent Metabolic Liability between Human and Mouse Lung Adenocarcinoma
Figure S6. TPI1 allelic variants effects central carbon metabolic flux.
- Open Access
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Figure S4 from LKB1-Dependent Regulation of TPI1 Creates a Divergent Metabolic Liability between Human and Mouse Lung Adenocarcinoma
Figure S4. Members of the salt Inducible kinase family phosphorylate TPI1.
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from LKB1-Dependent Regulation of TPI1 Creates a Divergent Metabolic Liability between Human and Mouse Lung Adenocarcinoma
Figure S4. Members of the salt Inducible kinase family phosphorylate TPI1.
- Open Access
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Figure S8 from LKB1-Dependent Regulation of TPI1 Creates a Divergent Metabolic Liability between Human and Mouse Lung Adenocarcinoma
Figure S8. Tpi1 inactivation in KL autochthonous tumor model alters histology and pathology.
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S8 from LKB1-Dependent Regulation of TPI1 Creates a Divergent Metabolic Liability between Human and Mouse Lung Adenocarcinoma
Figure S8. Tpi1 inactivation in KL autochthonous tumor model alters histology and pathology.
- Open Access
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Figure S7 from LKB1-Dependent Regulation of TPI1 Creates a Divergent Metabolic Liability between Human and Mouse Lung Adenocarcinoma
Figure S7. Tpi1 is required for tumor growth in KP and KPL LUAD models.
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S7 from LKB1-Dependent Regulation of TPI1 Creates a Divergent Metabolic Liability between Human and Mouse Lung Adenocarcinoma
Figure S7. Tpi1 is required for tumor growth in KP and KPL LUAD models.
- Open Access
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Figure S8 from LKB1-Dependent Regulation of TPI1 Creates a Divergent Metabolic Liability between Human and Mouse Lung Adenocarcinoma
Figure S8. Tpi1 inactivation in KL autochthonous tumor model alters histology and pathology.
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S8 from LKB1-Dependent Regulation of TPI1 Creates a Divergent Metabolic Liability between Human and Mouse Lung Adenocarcinoma
Figure S8. Tpi1 inactivation in KL autochthonous tumor model alters histology and pathology.
- Open Access
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Figure S2 from LKB1-Dependent Regulation of TPI1 Creates a Divergent Metabolic Liability between Human and Mouse Lung Adenocarcinoma
Figure S2. Phosphorylation of human TPI1 is LKB1-dependent.
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from LKB1-Dependent Regulation of TPI1 Creates a Divergent Metabolic Liability between Human and Mouse Lung Adenocarcinoma
Figure S2. Phosphorylation of human TPI1 is LKB1-dependent.